The AIR pulmonary drug delivery technology being developed at Alkermes provides targeted delivery of small-molecule or macromolecule drug particles from an easy-to-use, capsule-based, hand-held inhaler. When the patient inhales through the mouthpiece, air is drawn into the aerosolization chamber, agitating a capsule and releasing dry-powder medicine for systemic or local delivery to the lungs. To optimize future inhaler designs, Alkermes developed a test method to understand the behavior of the capsule under a range of operating conditions—for example, a range of air flows representing patients of differing age and size.
2009-05-18 08:00 AM
更多...